Unfortunately during conference calls, I have learned NOT to expect earth/shattering news from the company. Mostly "overviews" of the ongoing proceedings and updates. I have been disappointed far to often waiting for substantial news during these conferences. This is an "open" trial, so if very good news from the trials is witnessed that could/should be revealed by the company in a press release and/or news article in prestigious medical journal. But knowing how "our boy" Rabin works its a crapshoot. -- Sorry had to use a gambling term when referring to our "CEO", who hopefully if trials are successful will no longer be our "CEO".
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.